Thoracic Oncology for the Cardiothoracic Surgeon: What You Really Need to Know in 2025

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Mara Antonoff, MD
Disclosure(s): BMS, AZ, Merck, Ethicon: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing)

Brian Mitzman, MD, MS
Disclosure(s): Intuitive Surgical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Presentations

  1. When to Refer for Neoadjuvant
    Stephen Broderick, MD, MPHS
    Disclosure(s): Astrazeneca: Advisory Board (Terminated, February 1, 2024); Bristol Meyers Squibb: Advisory Board (Ongoing), Consultant (Ongoing)
     
  2. When to Do a Sublobar Resection
    Daniel Boffa, MD
    Disclosure(s): Epic Sciences: Consultant (Ongoing); Iovance: Advisory Board (Ongoing)
     
  3. When to Refer for Adjuvant XRT/Systemic
    Linda W. Martin, MD, MPH
    Disclosure(s): BMS: Speaker (Terminated, May 6, 2024)
     
  4. What's Adequate Staging/Profiling?
    DuyKhanh P. Ceppa, MD
    Disclosure(s): Medtronic: Consultant (Ongoing); Aztra zeneka: Advisory Board (Ongoing), Consultant (Ongoing); Cook Medical: Consultant (Ongoing)
     
  5. Discussion
Activity summary
Available credit: 
  • 1.00 ABS Accredited CME
  • 1.00 ABTS Accredited CME
  • 1.00 AMA PRA Category 1 Credit
Activity opens: 
03/01/2025
Activity expires: 
03/01/2028
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 ABS Accredited CME
  • 1.00 ABTS Accredited CME
  • 1.00 AMA PRA Category 1 Credit

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Mara Antonoff, MD
Disclosure(s): BMS, AZ, Merck, Ethicon: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing)

Brian Mitzman, MD, MS
Disclosure(s): Intuitive Surgical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Presentations

  1. When to Refer for Neoadjuvant
    Stephen Broderick, MD, MPHS
    Disclosure(s): Astrazeneca: Advisory Board (Terminated, February 1, 2024); Bristol Meyers Squibb: Advisory Board (Ongoing), Consultant (Ongoing)
     
  2. When to Do a Sublobar Resection
    Daniel Boffa, MD
    Disclosure(s): Epic Sciences: Consultant (Ongoing); Iovance: Advisory Board (Ongoing)
     
  3. When to Refer for Adjuvant XRT/Systemic
    Linda W. Martin, MD, MPH
    Disclosure(s): BMS: Speaker (Terminated, May 6, 2024)
     
  4. What's Adequate Staging/Profiling?
    DuyKhanh P. Ceppa, MD
    Disclosure(s): Medtronic: Consultant (Ongoing); Aztra zeneka: Advisory Board (Ongoing), Consultant (Ongoing); Cook Medical: Consultant (Ongoing)
     
  5. Discussion